FACULTY OF PHARMACY
Pharm. D. YDC) IV Year (Main) Examination, September 2017
Subject: Pharmacotherapeutics III
Time: 3 Hours Max.Marks: 70
Note: Answer all questions from Part A. Answer any five questions from Part B.
PART A (10x2 20 Marks)
1. Etiology of Venous thromboembolism. 2
2. Differentiate between gastric and duodenal ulcers. 2
3. Write briefly about the management of hepatic encephalopathy. 2
4. List out the different hepatitis viruses with their mode of transmission. 2
5. Write a brief note on hemolytic anemia. 2
6. Write the staging of Parkinsons according to Hoehn and Yahr scale. 2
7. Clinical presentation of a patient with generalized anxiety disorder. 2
8. Write the pharmacological management for obstructive sleep apnea. 2
9. Classify different types of pain with examples. 2
10. Differentiate the characteristics of tension and cluster headaches. 2
PART B (5x10 50 Marks)
11.(a) Write briefly the significance of validity and the types of bias in evidenced based
medicine. 4
Elaborate on the pathophysiologic mechanisms involved in epilepsy. 6
12.(a) Prehospital management of stroke. 5
Etiopathogenesis of GERD. 5
13.(a) Give a schematic representation of the pathogenesis of pulmonary hypertension,
varices and variceal hemorrhage. 6
Write a note on jaundice and its management. 4
14. Discuss in detail the etiology, prevention and pharmacological management of
Hepatitis B. 10
15.(a) Write in detail the role of Carbidopa/levodopa and its motor complications in the
management of Parkinson's disease. 6
Write a note on narcolepsy and its management. 4
16.(a) Elaborate on the adverse effects of antipsychotic agents used in management of
schizophrenia. 6
Clinical presentation of a patient with migraine headache. 4
17.(a) Elaborate the role of 5 amino salicylate derivatives and their various formulations
in the treatment of IBD. 7
Different scales used to evaluate patients with Alzheimer's disease. 3
18.(a) Elaborate on heparin induced thrombocytopenia and its management. 6
Use and adverse effects of benzodiazepines in generalized anxiety disorder. 4